Your browser doesn't support javascript.
loading
Value of liver biopsy in the diagnosis of drug-induced liver injury.
Ahmad, Jawad; Barnhart, Huiman X; Bonacini, Maurizio; Ghabril, Marwan; Hayashi, Paul H; Odin, Joseph A; Rockey, Don C; Rossi, Simona; Serrano, Jose; Tillmann, Hans L; Kleiner, David E.
Afiliación
  • Ahmad J; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, United States. Electronic address: jawad.ahmad@mountsinai.org.
  • Barnhart HX; Duke Clinical Research Institute, Durham, NC, United States.
  • Bonacini M; California Pacific Medical Center, San Francisco, CA, United States.
  • Ghabril M; Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, United States.
  • Hayashi PH; Food and Drug Administration, Silver Spring, MD, United States.
  • Odin JA; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, United States.
  • Rockey DC; Medical University of South Carolina, Charleston, SC, United States.
  • Rossi S; Einstein Medical Center, Philadelphia, PA, United States.
  • Serrano J; Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, United States.
  • Tillmann HL; Division of Gastroenterology, Hepatology and Nutrition, East Carolina University, Greenville, NC, United States.
  • Kleiner DE; Laboratory of Pathology, National Cancer Institute (NCI), Bethesda, MD, United States.
J Hepatol ; 76(5): 1070-1078, 2022 05.
Article en En | MEDLINE | ID: mdl-35074471
ABSTRACT
BACKGROUND &

AIMS:

The utility of liver biopsy in diagnosing or staging idiosyncratic drug-induced liver injury (DILI) is unclear. The aim of this study was to determine whether liver histology impacted causality assessment in suspected DILI using a novel simulation model.

METHODS:

Fifty patients enrolled in the DILI Network (DILIN) who had liver biopsies performed within 60 days of DILI onset were randomly selected. All had standard DILIN consensus causality scoring using a 5-point scale (1=definite, 2=highly likely, 3=probable, 4=possible, 5=unlikely) based on 6-month post-injury data. Three experienced hepatologists independently performed a causality assessment using redacted case records, with the biopsy and selected post-biopsy laboratory data removed. The 3 hepatologists also reviewed the liver histology with a hepatopathologist and then repeated causality assessment for each case.

RESULTS:

Of the 50 cases, there were 42 high causality DILI cases (1, 2 or 3) and 8 low causality cases (4 and 5). The hepatologists judged that liver biopsy was indicated in 62% of patients; after histology review, biopsy was judged to have been helpful in 70% of patients. Histology review changed the causality score in 68% of patients, with an increase in DILI likelihood in 48% and a decrease in 20%. Biopsy results changed diagnostic certainty from less certain (3 or 4) to highly certain (1, 2 or 5) in 38% of patients.

CONCLUSIONS:

Liver histologic findings may help clarify the diagnosis of DILI. Histology appears to be particularly helpful in cholestatic or equivocal cases of DILI (possible or probable), shifting assessment toward a greater or lower certainty of a DILI diagnosis. LAY

SUMMARY:

The utility of liver biopsy in diagnosing or staging idiosyncratic drug-induced liver injury (DILI) is unclear. Herein, we show that, in patients with suspected DILI, a liver biopsy can help physicians diagnose DILI or other causes of liver injury with more certainty.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Difilina / Enfermedad Hepática Inducida por Sustancias y Drogas Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Difilina / Enfermedad Hepática Inducida por Sustancias y Drogas Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article